COLL
Collegium Pharmaceutical Inc
23.00$
+1.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -4,386.5% | -235.3% | 60.4% | 9.4% | 30.3% | 37.4% | 26.8% | 48.5% | 32.5% | 42.2% | |
| – | – | 38.3% | 2.1% | 39.6% | 5.2% | 19.9% | 24.9% | 29.9% | 26.3% | 26.8% | 28.3% | |
| – | – | 338.2% | 27.9% | 4.9% | 5.6% | 7.1% | 8.8% | 4.9% | 4.8% | 5.1% | 5.4% | |
| – | – | 336.2% | 34.3% | 11.8% | 5.6% | 7.1% | -19.4% | 3.1% | – | – | – | |
| – | – | 743.1% | -8.8% | 23.0% | 8.1% | -8.2% | 4.9% | -2.7% | 3.8% | -8.7% | 0.5% | |
| – | – | 174.0% | 3.5% | 8.7% | 2.2% | 120.6% | 0.7% | 0.3% | 0.1% | 0.3% | 0.2% | |
| – | – | -174.0% | -3.5% | -8.7% | -2.2% | -120.6% | -0.7% | -123.7% | -12.5% | -45.6% | -8.1% | |
| – | – | 1,436.1% | 2.6% | – | – | 2.4% | 4.6% | – | 1.6% | – | – | |
| – | – | 1,436.1% | 4.0% | -0.2% | -0.3% | -0.7% | -17.3% | -3.0% | -13.2% | -9.5% | -3.2% | |
| – | – | -155.9% | -9.4% | 3.6% | 94.8% | 90.8% | -18.1% | -16.2% | -11.6% | 1.2% | -9.0% | |
| – | – | 7,922.7% | 117.6% | -41.8% | 0.7% | 92.4% | -32.3% | 94.1% | -24.7% | -9.6% | -14.1% | |
| – | – | 3,362.2% | -121.3% | 9.9% | 7.9% | 2.1% | 4.4% | -2.7% | 11.2% | -22.7% | 19.9% | |
| – | – | -4,560.5% | -238.8% | 51.7% | 7.2% | -90.3% | 36.7% | 26.4% | 48.4% | 32.2% | 42.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.